These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20304818)

  • 1. Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.
    Rengo G; Leosco D; Zincarelli C; Marchese M; Corbi G; Liccardo D; Filippelli A; Ferrara N; Lisanti MP; Koch WJ; Lymperopoulos A
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2032-8. PubMed ID: 20304818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Femminella G; Liccardo D; Pagano G; de Lucia C; Cannavo A; Gargiulo P; Ferrara N; Perrone Filardi P; Koch W; Leosco D
    Br J Pharmacol; 2012 Aug; 166(8):2430-40. PubMed ID: 22519418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
    Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
    J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells.
    Jafferjee M; Reyes Valero T; Marrero C; McCrink KA; Brill A; Lymperopoulos A
    Mol Endocrinol; 2016 Mar; 30(3):372-81. PubMed ID: 26849467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.
    Rengo G; Galasso G; Femminella GD; Parisi V; Zincarelli C; Pagano G; De Lucia C; Cannavo A; Liccardo D; Marciano C; Vigorito C; Giallauria F; Ferrara N; Furgi G; Filardi PP; Koch WJ; Leosco D
    Eur J Prev Cardiol; 2014 Jan; 21(1):4-11. PubMed ID: 23689525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure.
    de Lucia C; Gambino G; Petraglia L; Elia A; Komici K; Femminella GD; D'Amico ML; Formisano R; Borghetti G; Liccardo D; Nolano M; Houser SR; Leosco D; Ferrara N; Koch WJ; Rengo G
    Circ Heart Fail; 2018 Mar; 11(3):e004153. PubMed ID: 29535114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity.
    Lymperopoulos A; Rengo G; Zincarelli C; Soltys S; Koch WJ
    Mol Ther; 2008 Feb; 16(2):302-7. PubMed ID: 18223549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exercise training on cardiovascular adrenergic system.
    Leosco D; Parisi V; Femminella GD; Formisano R; Petraglia L; Allocca E; Bonaduce D
    Front Physiol; 2013 Nov; 4():348. PubMed ID: 24348425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
    Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
    Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats.
    Cunha TF; Bechara LR; Bacurau AV; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ferreira JC; Brum PC
    J Appl Physiol (1985); 2017 Apr; 122(4):817-827. PubMed ID: 28104751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure.
    Lymperopoulos A; Rengo G; Funakoshi H; Eckhart AD; Koch WJ
    Nat Med; 2007 Mar; 13(3):315-23. PubMed ID: 17322894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
    Kamal FA; Mickelsen DM; Wegman KM; Travers JG; Moalem J; Hammes SR; Smrcka AV; Blaxall BC
    J Am Coll Cardiol; 2014 Jun; 63(23):2549-2557. PubMed ID: 24703913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice.
    Medeiros A; Rolim NP; Oliveira RS; Rosa KT; Mattos KC; Casarini DE; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
    J Appl Physiol (1985); 2008 Jan; 104(1):103-9. PubMed ID: 17975126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin-3-gallate, the major green tea catechin, regulates the desensitization of β1 adrenoceptor via GRK2 in experimental heart failure.
    Zhang Q; Hu L; Chen L; Li H; Wu J; Liu W; Zhang M; Yan G
    Inflammopharmacology; 2018 Aug; 26(4):1081-1091. PubMed ID: 29247373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure.
    Rengo G; Pagano G; Paolillo S; de Lucia C; Femminella GD; Liccardo D; Cannavo A; Formisano R; Petraglia L; Komici K; Rengo F; Trimarco B; Ferrara N; Leosco D; Perrone-Filardi P
    Eur J Clin Invest; 2015 Feb; 45(2):187-95. PubMed ID: 25545706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.
    Bathgate-Siryk A; Dabul S; Pandya K; Walklett K; Rengo G; Cannavo A; De Lucia C; Liccardo D; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Hypertension; 2014 Feb; 63(2):404-12. PubMed ID: 24218435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.